Title of article :
Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
Author/Authors :
E Tauber، نويسنده , , H Kollaritsch، نويسنده , , M Korinek، نويسنده , , P Rendi-Wagner، نويسنده , , Bernd Jilma، نويسنده , , C Firbas، نويسنده , , S Schranz، نويسنده , , E Jong، نويسنده , , A Klingler، نويسنده , , S Dewasthaly، نويسنده , , CS Klade، نويسنده ,
Abstract :
Background
Japanese encephalitis virus (JEV) is the leading cause of viral encephalitis in southeast Asia. Although no treatment is currently available, vaccination effectively prevents the disease. In a non-inferiority study, we aimed to compare the safe
